TABLE 4.
The top 10 most cited articles from 2004 to 2021.
| Title | Authors | Journal | Citations | IF (2020) | H-index |
|---|---|---|---|---|---|
| The orphan receptor GPR55 is a novel cannabinoid receptor | Ryberg, E, et al. | British Journal of Pharmacology | 984 | 8.739 | 211 |
| The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta (9)-tetrahydrocannabinol, cannabidiol and Delta (9)-tetrahydrocannabivarin | Pertwee, RG. | British Journal of Pharmacology | 955 | 8.739 | 211 |
| Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects | Russo, Ethan B, et al. | British Journal of Pharmacology | 664 | 8.739 | 211 |
| Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome | Devinsky, O, et al. | New England Journal of Medicine | 628 | 91.253 | 1030 |
| Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia | Leweke, FM, et al. | Translational Psychiatry | 547 | 6.222 | 82 |
| The Endocannabinoid System and the Brain | Mechoulam, R, et al. | Annual Review of Psychology | 528 | 24.137 | 243 |
| Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb | Izzo, AA, et al. | Trends in Pharmacological Sciences | 491 | 14.819 | 218 |
| Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders | Devinsky, O, et al. | Epilepsia | 459 | 5.866 | 191 |
| Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States | ElSohly, MA, et al. | Biological Psychiatry | 450 | 13.382 | 319 |
| Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial | Devinsky, O, et al. | Lancet Neurology | 444 | 44.182 | 291 |